Stay updated on Pembrolizumab & Romidepsin Combo Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Romidepsin Combo Clinical Trial page.

Latest updates to the Pembrolizumab & Romidepsin Combo Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record for the pembrolizumab and romidepsin trial is now displayed, with details about its design, participants, outcomes, and study documents. It indicates that the study is completed and no longer recruiting.SummaryDifference58%

- Check19 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check40 days agoChange DetectedThe displayed site revision advances from v3.7.0 to v3.7.1, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check61 days agoChange DetectedRevision: v3.7.0 was added in the page footer, and a broad set of terms and an institution name were removed from the metadata sections. These appear to be administrative cleanup of metadata rather than substantive changes to the study details.SummaryDifference20%

Stay in the know with updates to Pembrolizumab & Romidepsin Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Romidepsin Combo Clinical Trial page.